Shitara, K., Yamazaki, K., Tsushima, T., Naito, T., Matsubara, N., Watanabe, M., . . . Doi, T. (2020). Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumors. Jpn J Clin Oncol.

Shitara, Kohei, Kentaro Yamazaki, Takahiro Tsushima, Tateaki Naito, Nobuaki Matsubara, Morihiro Watanabe, Barbara Sarholz, Andreas Johne, et Toshihiko Doi. "Phase I Trial of the MET Inhibitor Tepotinib in Japanese Patients With Solid Tumors." Jpn J Clin Oncol 2020.

Shitara, Kohei, et al. "Phase I Trial of the MET Inhibitor Tepotinib in Japanese Patients With Solid Tumors." Jpn J Clin Oncol 2020.